Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Late-onset
100%
X-linked Adrenoleukodystrophy (X-ALD)
100%
PEX6
100%
Zellweger Spectrum Disorder
100%
New Patients
33%
Cause of Disease
16%
Clinical Diagnosis
16%
Gene Defects
16%
Fatty Acid Composition
16%
Neurodegenerative Diseases
16%
Patient Management
16%
Brain Magnetic Resonance Imaging
16%
Disease Course
16%
Cognitive Dysfunction
16%
Normal Development
16%
Bilateral Sensorineural Hearing Loss
16%
Compound Heterozygous mutation
16%
Diplopia
16%
Coding Sequence
16%
Skin Fibroblasts
16%
Long-chain Polyunsaturated Fatty Acids (LC-PUFA)
16%
Genetic Counseling
16%
Multisystem Disease
16%
Acute Onset
16%
Peroxisomal Enzymes
16%
Peroxisomal
16%
Enzyme Deficiency
16%
PEX Genes
16%
Molecular Confirmation
16%
Cultured Skin
16%
Biochemical Diagnosis
16%
Clumsiness
16%
Patient Characterization
16%
Genetic Management
16%
Leukodystrophy
16%
ABCD1 Gene
16%
Hearing Tests
16%
Molecular Testing
16%
Disorder Diagnosis
16%
Gadolinium Enhancement
16%
Medicine and Dentistry
Spectrum Disorder
100%
Adrenoleukodystrophy
100%
Diseases
33%
Sensorineural Hearing Loss
16%
Cognitive Defect
16%
Disease Course
16%
Diplopia
16%
Genetic Counseling
16%
Enzyme Deficiency
16%
Degenerative Disease
16%
Magnetic Resonance Imaging of the Brain
16%
Skin Fibroblast
16%
ABCD1
16%
Leukodystrophy
16%
Hearing Test
16%
Gadolinium
16%
Very Long Chain Fatty Acid
16%
Neuroscience
Spectrum Disorder
100%
Adrenoleukodystrophy
100%
Magnetic Resonance Imaging
16%
Cognitive Disorders
16%
Sensorineural Hearing Loss
16%
Sensation of Hearing
16%
Neurodegenerative Disorder
16%
Enzymes
16%
Diplopia
16%
Leukodystrophy
16%
Blood Plasma
16%
Fibroblast
16%
Very Long Chain Fatty Acid
16%
Genetics
16%